{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:51:58Z","timestamp":1776239518669,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Very rare polymorphisms in the human <jats:italic>VRK1<\/jats:italic> (vaccinia-related kinase 1) gene have been identified in complex neuromotor phenotypes associated to spinal muscular atrophy (SMA), pontocerebellar hypoplasia (PCH), microcephaly, amyotrophic lateral sclerosis (ALS) and distal motor neuron dysfunctions. The mechanisms by which these VRK1 variant proteins contribute to the pathogenesis of these neurological syndromes are unknown. The syndromes are manifested when both of these rare <jats:italic>VRK1<\/jats:italic> polymorphic alleles are implicated, either in homozygosis or compound heterozygosis. In this report, to identify the common underlying pathogenic mechanism of <jats:italic>VRK1<\/jats:italic> polymorphisms, we have studied all human VRK1 variants identified in these neurological phenotypes from a biochemical point of view by molecular modeling, protein stability and kinase activity assays. Molecular modelling predicted that VRK1 variant proteins are either unstable or have an altered kinase activity. The stability and kinase activity of VRK1 pathogenic variants detected two groups. One composed by variants with a reduced protein stability: R133C, R358X, L195V, G135R and R321C. The other group includes VRK1variants with a reduced kinase activity tested on several substrates: histones H3 and H2AX, p53, c-Jun, coilin and 53BP1, a DNA repair protein. VRK1 variants with reduced kinase activity are H119R, R133C, G135R, V236M, R321C and R358X. The common underlying effect of VRK1 pathogenic variants with reduced protein stability or kinase activity is a functional insufficiency of VRK1 in patients with neuromotor developmental syndromes. The G135 variant cause a defective formation of 53BP1 foci in response to DNA damage, and loss Cajal bodies assembled on coilin.<\/jats:p>","DOI":"10.1038\/s41598-019-49821-7","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T10:05:08Z","timestamp":1568628308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8397-9952","authenticated-orcid":false,"given":"Elena","family":"Mart\u00edn-Doncel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-9099","authenticated-orcid":false,"given":"Ana M.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-5262","authenticated-orcid":false,"given":"Lara","family":"Cantarero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8997-3025","authenticated-orcid":false,"given":"Pedro A.","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"49821_CR1","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1128\/MCB.00018-07","volume":"27","author":"TH Kang","year":"2007","unstructured":"Kang, T. H. et al. Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol. Cell. Biol. 27, 8533\u20138546, https:\/\/doi.org\/10.1128\/MCB.00018-07 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"49821_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15592294.2015.1028708","volume":"10","author":"M Salzano","year":"2015","unstructured":"Salzano, M., Sanz-Garcia, M., Monsalve, D. M., Moura, D. S. & Lazo, P. A. VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage. Epigenetics 10, 373\u2013383, https:\/\/doi.org\/10.1080\/15592294.2015.1028708 (2015).","journal-title":"Epigenetics"},{"key":"49821_CR3","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00018-018-2746-7","volume":"76","author":"DS Moura","year":"2018","unstructured":"Moura, D. S., Campillo-Marcos, I., Vazquez-Cedeira, M. & Lazo, P. A. VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis. Cell Mol Life Sci 76, 2591\u20132611, https:\/\/doi.org\/10.1007\/s00018-018-2746-7 (2018).","journal-title":"Cell Mol Life Sci"},{"key":"49821_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.molcel.2016.09.012","volume":"64","author":"H Aihara","year":"2016","unstructured":"Aihara, H. et al. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1. Mol Cell 64, 176\u2013188, https:\/\/doi.org\/10.1016\/j.molcel.2016.09.012 (2016).","journal-title":"Mol Cell"},{"key":"49821_CR5","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1038\/sj.onc.1203709","volume":"19","author":"S Lopez-Borges","year":"2000","unstructured":"Lopez-Borges, S. & Lazo, P. A. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19, 3656\u20133664, https:\/\/doi.org\/10.1038\/sj.onc.1203709 (2000).","journal-title":"Oncogene"},{"key":"49821_CR6","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/MCB.24.23.10366-10380.2004","volume":"24","author":"FM Vega","year":"2004","unstructured":"Vega, F. M., Sevilla, A. & Lazo, P. A. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1. Mol. Cell. Biol. 24, 10366\u201310380, https:\/\/doi.org\/10.1128\/MCB.24.23.10366-10380.2004 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"49821_CR7","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.1038\/sj.onc.1208015","volume":"23","author":"A Sevilla","year":"2004","unstructured":"Sevilla, A., Santos, C. R., Barcia, R., Vega, F. M. & Lazo, P. A. c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23, 8950\u20138958, https:\/\/doi.org\/10.1038\/sj.onc.1208015 (2004).","journal-title":"Oncogene"},{"key":"49821_CR8","doi-asserted-by":"publisher","first-page":"27458","DOI":"10.1074\/jbc.M401009200","volume":"279","author":"A Sevilla","year":"2004","unstructured":"Sevilla, A., Santos, C. R., Vega, F. M. & Lazo, P. A. Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279, 27458\u201327465, https:\/\/doi.org\/10.1074\/jbc.M401009200 (2004).","journal-title":"J. Biol. Chem."},{"key":"49821_CR9","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1242\/jcs.026757","volume":"121","author":"TH Kang","year":"2008","unstructured":"Kang, T. H., Park, D. Y., Kim, W. & Kim, K. T. VRK1 phosphorylates CREB and mediates CCND1 expression. J. Cell. Sci. 121, 3035\u20133041, https:\/\/doi.org\/10.1242\/jcs.026757 (2008).","journal-title":"J. Cell. Sci."},{"key":"49821_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1210\/me.2016-1105","volume":"30","author":"T Hashiguchi","year":"2016","unstructured":"Hashiguchi, T. et al. Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation. Mol Endocrinol 30, 1070\u20131080, https:\/\/doi.org\/10.1210\/me.2016-1105 (2016).","journal-title":"Mol Endocrinol"},{"key":"49821_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbamcr.2016.02.005","volume":"1863","author":"DM Monsalve","year":"2016","unstructured":"Monsalve, D. M. et al. VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage. BBA Mol. Cell Res. 1863, 760\u2013769, https:\/\/doi.org\/10.1016\/j.bbamcr.2016.02.005 (2016).","journal-title":"BBA Mol. Cell Res."},{"key":"49821_CR12","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1074\/jbc.M112.353102","volume":"287","author":"M Sanz-Garcia","year":"2012","unstructured":"Sanz-Garcia, M., Monsalve, D. M., Sevilla, A. & Lazo, P. A. Vaccinia-related Kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. J. Biol. Chem. 287, 23757\u201323768, https:\/\/doi.org\/10.1074\/jbc.M112.353102 (2012).","journal-title":"J. Biol. Chem."},{"key":"49821_CR13","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1371\/journal.pone.0001642","volume":"3","author":"A Valbuena","year":"2008","unstructured":"Valbuena, A., Lopez-Sanchez, I. & Lazo, P. A. Human VRK1 is an early response gene and its loss causes a block in cell cycle progression. PLoS One 3, e1642, https:\/\/doi.org\/10.1371\/journal.pone.0001642 (2008).","journal-title":"PLoS One"},{"key":"49821_CR14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cellsig.2011.04.002","volume":"23","author":"A Valbuena","year":"2011","unstructured":"Valbuena, A., Sanz-Garcia, M., Lopez-Sanchez, I., Vega, F. M. & Lazo, P. A. Roles of VRK1 as a new player in the control of biological processes required for cell division. Cell. Signal. 23, 1267\u20131272, https:\/\/doi.org\/10.1016\/j.cellsig.2011.04.002 (2011).","journal-title":"Cell. Signal."},{"key":"49821_CR15","unstructured":"Sanz-Garcia, M. et al. In Emerging Signaling Pathways in Tumor Biology (ed. Lazo, P. A.) 135\u2013156 (Transworld Research Networks, 2010)."},{"key":"49821_CR16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00018-018-2811-2","volume":"75","author":"I Campillo-Marcos","year":"2018","unstructured":"Campillo-Marcos, I. & Lazo, P. A. Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target? Cell Mol Life Sci 75, 2375\u20132388, https:\/\/doi.org\/10.1007\/s00018-018-2811-2 (2018).","journal-title":"Cell Mol Life Sci"},{"key":"49821_CR17","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1093\/nar\/gks634","volume":"40","author":"YH Choi","year":"2012","unstructured":"Choi, Y. H., Lim, J. K., Jeong, M. W. & Kim, K. T. HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence. Nucleic Acids Res. 40, 8499\u20138518, https:\/\/doi.org\/10.1093\/nar\/gks634 (2012).","journal-title":"Nucleic Acids Res."},{"key":"49821_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1128\/MCB.01341-08","volume":"29","author":"I Lopez-Sanchez","year":"2009","unstructured":"Lopez-Sanchez, I., Sanz-Garcia, M. & Lazo, P. A. Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation. Mol. Cell. Biol. 29, 1189\u20131201, https:\/\/doi.org\/10.1128\/MCB.01341-08 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"49821_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep10543","volume":"5","author":"L Cantarero","year":"2015","unstructured":"Cantarero, L. et al. VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle. Sci Rep 5, 10543, https:\/\/doi.org\/10.1038\/srep10543 (2015).","journal-title":"Sci Rep"},{"key":"49821_CR20","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1091\/mbc.E05-12-1179","volume":"17","author":"RJ Nichols","year":"2006","unstructured":"Nichols, R. J., Wiebe, M. S. & Traktman, P. The vaccinia-related kinases phosphorylate the N\u2019 terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol. Biol. Cell. 17, 2451\u20132464, https:\/\/doi.org\/10.1091\/mbc.E05-12-1179 (2006).","journal-title":"Mol. Biol. Cell."},{"key":"49821_CR21","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1007\/s00018-018-2900-2","volume":"75","author":"FT Bianchi","year":"2018","unstructured":"Bianchi, F. T., Berto, G. E. & Di Cunto, F. Impact of DNA repair and stability defects on cortical development. Cell Mol Life Sci 75, 3963\u20133976, https:\/\/doi.org\/10.1007\/s00018-018-2900-2 (2018).","journal-title":"Cell Mol Life Sci"},{"key":"49821_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ajhg.2009.07.006","volume":"85","author":"P Renbaum","year":"2009","unstructured":"Renbaum, P. et al. Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. Am. J. Hum. Genet. 85, 281\u2013289, https:\/\/doi.org\/10.1016\/j.ajhg.2009.07.006 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"49821_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jprot.2011.08.019","volume":"75","author":"M Sanz-Garcia","year":"2011","unstructured":"Sanz-Garcia, M. et al. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications. J. Proteomics 75, 548\u2013560, https:\/\/doi.org\/10.1016\/j.jprot.2011.08.019 (2011).","journal-title":"J. Proteomics"},{"key":"49821_CR24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/jamaneurol.2013.4598","volume":"70","author":"C Gonzaga-Jauregui","year":"2013","unstructured":"Gonzaga-Jauregui, C. et al. Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly. JAMA Neurol. 70, 1491\u20131498, https:\/\/doi.org\/10.1001\/jamaneurol.2013.4598 (2013).","journal-title":"JAMA Neurol."},{"key":"49821_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/CND.0000000000000096","volume":"17","author":"TP Nguyen","year":"2015","unstructured":"Nguyen, T. P., Biliciler, S., Wiszniewski, W. & Sheikh, K. Expanding Phenotype of VRK1 Mutations in Motor Neuron Disease. J Clin Neuromuscul Dis 17, 69\u201371, https:\/\/doi.org\/10.1097\/CND.0000000000000096 (2015).","journal-title":"J Clin Neuromuscul Dis"},{"key":"49821_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10423","volume":"478","author":"H Najmabadi","year":"2011","unstructured":"Najmabadi, H. et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478, 57\u201363, https:\/\/doi.org\/10.1038\/nature10423 (2011).","journal-title":"Nature"},{"key":"49821_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0b013e3181ec800c","volume":"75","author":"MB Harms","year":"2010","unstructured":"Harms, M. B. et al. Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32. Neurology 75, 539\u2013546, https:\/\/doi.org\/10.1212\/WNL.0b013e3181ec800c (2010).","journal-title":"Neurology"},{"key":"49821_CR28","doi-asserted-by":"publisher","unstructured":"Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv, 531210, https:\/\/doi.org\/10.1101\/531210 (2019).","DOI":"10.1101\/531210"},{"key":"49821_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.str.2008.10.018","volume":"17","author":"ED Scheeff","year":"2009","unstructured":"Scheeff, E. D., Eswaran, J., Bunkoczi, G., Knapp, S. & Manning, G. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure 17, 128\u2013138, https:\/\/doi.org\/10.1016\/j.str.2008.10.018 (2009).","journal-title":"Structure"},{"key":"49821_CR30","doi-asserted-by":"publisher","first-page":"22131","DOI":"10.1074\/jbc.M110.200162","volume":"286","author":"J Shin","year":"2011","unstructured":"Shin, J. et al. NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity. J. Biol. Chem. 286, 22131\u201322138, https:\/\/doi.org\/10.1074\/jbc.M110.200162 (2011).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"49821_CR31","doi-asserted-by":"publisher","first-page":"140121","DOI":"10.1098\/rsob.140121","volume":"4","author":"Romain A. Studer","year":"2014","unstructured":"Studer, R. A., Opperdoes, F. R., Nicolaes, G. A., Mulder, A. B. & Mulder, R. Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach. Open Biol 4, https:\/\/doi.org\/10.1098\/rsob.140121 (2014).","journal-title":"Open Biology"},{"key":"49821_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/abbi.2001.2746","volume":"399","author":"R Barcia","year":"2002","unstructured":"Barcia, R., Lopez-Borges, S., Vega, F. M. & Lazo, P. A. Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1. Arch. Biochem. Biophys. 399, 1\u20135, https:\/\/doi.org\/10.1006\/abbi.2001.2746 (2002).","journal-title":"Arch. Biochem. Biophys."},{"key":"49821_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00775-013-0992-6","volume":"18","author":"I Barcia-Sanjurjo","year":"2013","unstructured":"Barcia-Sanjurjo, I., Vazquez-Cedeira, M., Barcia, R. & Lazo, P. A. Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals. J. Biol. Inorg. Chem. 18, 473\u2013482, https:\/\/doi.org\/10.1007\/s00775-013-0992-6 (2013).","journal-title":"J. Biol. Inorg. Chem."},{"key":"49821_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.febslet.2014.01.040","volume":"588","author":"I Lopez-Sanchez","year":"2014","unstructured":"Lopez-Sanchez, I. et al. VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage. FEBS Lett. 588, 692\u2013700, https:\/\/doi.org\/10.1016\/j.febslet.2014.01.040 (2014).","journal-title":"FEBS Lett."},{"key":"49821_CR35","doi-asserted-by":"publisher","first-page":"e17320","DOI":"10.1371\/journal.pone.0017320","volume":"6","author":"A Valbuena","year":"2011","unstructured":"Valbuena, A., Castro-Obregon, S. & Lazo, P. A. Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway. PLoS One 6, e17320, https:\/\/doi.org\/10.1371\/journal.pone.0017320 (2011).","journal-title":"PLoS One"},{"key":"49821_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","volume":"10","author":"YT Ip","year":"1998","unstructured":"Ip, Y. T. & Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK)\u2013from inflammation to development. Curr Opin Cell Biol 10, 205\u2013219 (1998).","journal-title":"Curr Opin Cell Biol"},{"key":"49821_CR37","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.18632\/oncotarget.1678","volume":"5","author":"M Salzano","year":"2014","unstructured":"Salzano, M. et al. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response. Oncotarget 5, 1770\u20131778, https:\/\/doi.org\/10.18632\/oncotarget.1678 (2014).","journal-title":"Oncotarget"},{"key":"49821_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1083\/jcb.200311121","volume":"164","author":"M Dundr","year":"2004","unstructured":"Dundr, M. et al. In vivo kinetics of Cajal body components. J. Cell. Biol. 164, 831\u2013842, https:\/\/doi.org\/10.1083\/jcb.200311121 (2004).","journal-title":"J. Cell. Biol."},{"key":"49821_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0925-4439(03)00038-3","volume":"1638","author":"S Hong","year":"2003","unstructured":"Hong, S., Ka, S., Kim, S., Park, Y. & Kang, S. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product. Biochim. Biophys. Acta 1638, 35\u201342, https:\/\/doi.org\/10.1016\/S0925-4439(03)00038-3 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"49821_CR40","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/hmg\/ddw021","volume":"25","author":"KJ Han","year":"2016","unstructured":"Han, K. J. et al. Monoubiquitination of survival motor neuron regulates its cellular localization and Cajal body integrity. Hum Mol Genet 25, 1392\u20131405, https:\/\/doi.org\/10.1093\/hmg\/ddw021 (2016).","journal-title":"Hum Mol Genet"},{"key":"49821_CR41","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1242\/jcs.044040","volume":"122","author":"SM Hearst","year":"2009","unstructured":"Hearst, S. M. et al. Cajal-body formation correlates with differential coilin phosphorylation in primary and transformed cell lines. J. Cell Sci. 122, 1872\u20131881, https:\/\/doi.org\/10.1242\/jcs.044040 (2009).","journal-title":"J. Cell Sci."},{"issue":"6","key":"49821_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/15476286.2016.1243649","volume":"14","author":"Michael D. Hebert","year":"2016","unstructured":"Hebert, M. D. & Poole, A. R. Toward an understanding of regulating Cajal body activity by protein modification. RNA Biol, 1\u201318, https:\/\/doi.org\/10.1080\/15476286.2016.1243649 (2016).","journal-title":"RNA Biology"},{"key":"49821_CR43","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1101\/gad.908401","volume":"15","author":"MD Hebert","year":"2001","unstructured":"Hebert, M. D., Szymczyk, P. W., Shpargel, K. B. & Matera, A. G. Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev. 15, 2720\u20132729, https:\/\/doi.org\/10.1101\/gad.908401 (2001).","journal-title":"Genes Dev."},{"key":"49821_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.115","volume":"3","author":"HZ Yin","year":"2012","unstructured":"Yin, H. Z. et al. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis 3, e374, https:\/\/doi.org\/10.1038\/cddis.2012.115 (2012).","journal-title":"Cell Death Dis"},{"key":"49821_CR45","doi-asserted-by":"publisher","first-page":"1488 e1415","DOI":"10.1016\/j.neurobiolaging.2011.11.022","volume":"33","author":"KL Williams","year":"2012","unstructured":"Williams, K. L., Solski, J. A., Nicholson, G. A. & Blair, I. P. Mutation analysis of VCP in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33, 1488 e1415\u20131486, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.11.022 (2012).","journal-title":"Neurobiol Aging"},{"key":"49821_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1212\/WNL.0000000000002813","volume":"87","author":"M Stoll","year":"2016","unstructured":"Stoll, M. et al. Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia. Neurology 87, 65\u201370, https:\/\/doi.org\/10.1212\/WNL.0000000000002813 (2016).","journal-title":"Neurology"},{"key":"49821_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-019-1204-1","volume":"38","author":"I Campillo-Marcos","year":"2019","unstructured":"Campillo-Marcos, I. & Lazo, P. A. Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase. J Exp Clin Cancer Res 38, 203, https:\/\/doi.org\/10.1186\/s13046-019-1204-1 (2019).","journal-title":"J Exp Clin Cancer Res"},{"key":"49821_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep28532","volume":"6","author":"DS Moura","year":"2016","unstructured":"Moura, D. S. et al. Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation. Sci Rep 6, 28532, https:\/\/doi.org\/10.1038\/srep28532 (2016).","journal-title":"Sci Rep"},{"key":"49821_CR49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1523\/JNEUROSCI.1998-14.2015","volume":"35","author":"H Vinograd-Byk","year":"2015","unstructured":"Vinograd-Byk, H. et al. The Spinal Muscular Atrophy with Pontocerebellar Hypoplasia Gene VRK1 Regulates Neuronal Migration through an Amyloid-beta Precursor Protein-Dependent Mechanism. J Neurosci 35, 936\u2013942, https:\/\/doi.org\/10.1523\/JNEUROSCI.1998-14.2015 (2015).","journal-title":"J Neurosci"},{"key":"49821_CR50","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1095\/biolreprod.109.079095","volume":"82","author":"MS Wiebe","year":"2010","unstructured":"Wiebe, M. S., Nichols, R. J., Molitor, T. P., Lindgren, J. K. & Traktman, P. Mice deficient in the serine\/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia. Biol. Reprod. 82, 182\u2013193, https:\/\/doi.org\/10.1095\/biolreprod.109.079095 (2010).","journal-title":"Biol. Reprod."},{"key":"49821_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29215-x","volume":"8","author":"H Vinograd-Byk","year":"2018","unstructured":"Vinograd-Byk, H., Renbaum, P. & Levy-Lahad, E. Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways. Sci Rep 8, 11265, https:\/\/doi.org\/10.1038\/s41598-018-29215-x (2018).","journal-title":"Sci Rep"},{"key":"49821_CR52","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1091\/mbc.E10-08-0717","volume":"22","author":"CH Park","year":"2011","unstructured":"Park, C. H. et al. Protein kinase Cdelta regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis. Mol. Biol. Cell 22, 1398\u20131408, https:\/\/doi.org\/10.1091\/mbc.E10-08-0717 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"49821_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/pro.3552","volume":"28","author":"YS Ngow","year":"2019","unstructured":"Ngow, Y. S., Rajan, S., Ye, H. & Yoon, H. S. Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP, a non-hydrolysable ATP analog. Protein Sci 28, 524\u2013532, https:\/\/doi.org\/10.1002\/pro.3552 (2019).","journal-title":"Protein Sci"},{"key":"49821_CR54","doi-asserted-by":"publisher","first-page":"e0122348","DOI":"10.1371\/journal.pone.0122348","volume":"10","author":"II Enwerem","year":"2015","unstructured":"Enwerem, I. I., Wu, G., Yu, Y. T. & Hebert, M. D. Cajal body proteins differentially affect the processing of box C\/D scaRNPs. PLoS One 10, e0122348, https:\/\/doi.org\/10.1371\/journal.pone.0122348 (2015).","journal-title":"PLoS One"},{"issue":"21","key":"49821_CR55","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00018-018-2849-1","volume":"75","author":"Helena Chaytow","year":"2018","unstructured":"Chaytow, H., Huang, Y. T., Gillingwater, T. H. & Faller, K. M. E. The role of survival motor neuron protein (SMN) in protein homeostasis. Cell Mol Life Sci, https:\/\/doi.org\/10.1007\/s00018-018-2849-1 (2018).","journal-title":"Cellular and Molecular Life Sciences"},{"key":"49821_CR56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00439-017-1835-2","volume":"136","author":"CE Dominguez","year":"2017","unstructured":"Dominguez, C. E., Cunningham, D. & Chandler, D. S. SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities. Hum Genet 136, 1173\u20131191, https:\/\/doi.org\/10.1007\/s00439-017-1835-2 (2017).","journal-title":"Hum Genet"},{"key":"49821_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pneurobio.2012.04.003","volume":"99","author":"HT Orr","year":"2012","unstructured":"Orr, H. T. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. Prog Neurobiol 99, 179\u2013185, https:\/\/doi.org\/10.1016\/j.pneurobio.2012.04.003 (2012).","journal-title":"Prog Neurobiol"},{"key":"49821_CR58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1471-4159.2009.06164.x","volume":"110","author":"ND Jorgensen","year":"2009","unstructured":"Jorgensen, N. D. et al. Phosphorylation of ATXN1 at Ser776 in the cerebellum. J Neurochem 110, 675\u2013686, https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06164.x (2009).","journal-title":"J Neurochem"},{"key":"49821_CR59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr, H. T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4, 221\u2013226, https:\/\/doi.org\/10.1038\/ng0793-221 (1993).","journal-title":"Nat Genet"},{"key":"49821_CR60","doi-asserted-by":"publisher","first-page":"837 e837","DOI":"10.1016\/j.neurobiolaging.2011.10.006","volume":"33","author":"M Koppers","year":"2012","unstructured":"Koppers, M. et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33, 837 e837\u2013813, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.10.006 (2012).","journal-title":"Neurobiol Aging"},{"key":"49821_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-319-89689-2_6","volume":"20","author":"PL Price","year":"2018","unstructured":"Price, P. L., Morderer, D. & Rossoll, W. RNP Assembly Defects in Spinal Muscular Atrophy. Adv Neurobiol 20, 143\u2013171, https:\/\/doi.org\/10.1007\/978-3-319-89689-2_6 (2018).","journal-title":"Adv Neurobiol"},{"key":"49821_CR62","doi-asserted-by":"publisher","first-page":"818","DOI":"10.14348\/molcells.2018.0243","volume":"41","author":"M Zhao","year":"2018","unstructured":"Zhao, M., Kim, J. R., van Bruggen, R. & Park, J. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Mol Cells 41, 818\u2013829, https:\/\/doi.org\/10.14348\/molcells.2018.0243 (2018).","journal-title":"Mol Cells"},{"key":"49821_CR63","doi-asserted-by":"publisher","first-page":"e0203397","DOI":"10.1371\/journal.pone.0203397","volume":"13","author":"AM Mon","year":"2018","unstructured":"Mon, A. M., MacKinnon, A. C. Jr. & Traktman, P. Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells. PLoS One 13, e0203397, https:\/\/doi.org\/10.1371\/journal.pone.0203397 (2018).","journal-title":"PLoS One"},{"issue":"8","key":"49821_CR64","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.bbadis.2018.10.019","volume":"1865","author":"Samantha N. Cobos","year":"2019","unstructured":"Cobos, S. N., Bennett, S. A. & Torrente, M. P. The impact of histone post-translational modifications in neurodegenerative diseases. Biochim Biophys Acta Mol Basis Dis, https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.019 (2018).","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"49821_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","volume":"41","author":"A Berson","year":"2018","unstructured":"Berson, A., Nativio, R., Berger, S. L. & Bonini, N. M. Epigenetic Regulation in Neurodegenerative Diseases. Trends Neurosci 41, 587\u2013598, https:\/\/doi.org\/10.1016\/j.tins.2018.05.005 (2018).","journal-title":"Trends Neurosci"},{"key":"49821_CR66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.genom.7.080505.115648","volume":"8","author":"PJ McKinnon","year":"2007","unstructured":"McKinnon, P. J. & Caldecott, K. W. DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet 8, 37\u201355 (2007).","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"49821_CR67","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.dnarep.2013.04.009","volume":"12","author":"S Sepe","year":"2013","unstructured":"Sepe, S., Payan-Gomez, C., Milanese, C., Hoeijmakers, J. H. & Mastroberardino, P. G. Nucleotide excision repair in chronic neurodegenerative diseases. DNA Repair (Amst) 12, 568\u2013577, https:\/\/doi.org\/10.1016\/j.dnarep.2013.04.009 (2013).","journal-title":"DNA Repair (Amst)"},{"key":"49821_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0065-227X(04)80076-5","volume":"38","author":"S Matsuura","year":"2004","unstructured":"Matsuura, S., Kobayashi, J., Tauchi, H. & Komatsu, K. Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex. Adv Biophys 38, 65\u201380 (2004).","journal-title":"Adv Biophys"},{"key":"49821_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0616-2","volume":"12","author":"V Natale","year":"2017","unstructured":"Natale, V. & Raquer, H. Xeroderma pigmentosum-Cockayne syndrome complex. Orphanet J Rare Dis 12, 65, https:\/\/doi.org\/10.1186\/s13023-017-0616-2 (2017).","journal-title":"Orphanet J Rare Dis"},{"key":"49821_CR70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/1673-5374.226377","volume":"13","author":"D Penndorf","year":"2018","unstructured":"Penndorf, D., Witte, O. W. & Kretz, A. DNA plasticity and damage in amyotrophic lateral sclerosis. Neural Regen Res 13, 173\u2013180, https:\/\/doi.org\/10.4103\/1673-5374.226377 (2018).","journal-title":"Neural Regen Res"},{"key":"49821_CR71","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.dnarep.2004.03.004","volume":"3","author":"M Digweed","year":"2004","unstructured":"Digweed, M. & Sperling, K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) 3, 1207\u20131217, https:\/\/doi.org\/10.1016\/j.dnarep.2004.03.004 (2004).","journal-title":"DNA Repair (Amst)"},{"key":"49821_CR72","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3892\/ijo.2012.1757","volume":"42","author":"R Wan","year":"2013","unstructured":"Wan, R., Wu, J., Baloue, K. K. & Crowe, D. L. Regulation of the Nijmegen breakage syndrome 1 gene NBS1 by c-myc, p53 and coactivators mediates estrogen protection from DNA damage in breast cancer cells. Int J Oncol 42, 712\u2013720, https:\/\/doi.org\/10.3892\/ijo.2012.1757 (2013).","journal-title":"Int J Oncol"},{"key":"49821_CR73","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1128\/MCB.00069-06","volume":"26","author":"A Valbuena","year":"2006","unstructured":"Valbuena, A., Vega, F. M., Blanco, S. & Lazo, P. A. p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop. Mol. Cell. Biol. 26, 4782\u20134793, https:\/\/doi.org\/10.1128\/MCB.00069-06 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"49821_CR74","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrneurol.2009.26","volume":"5","author":"JB Schulz","year":"2009","unstructured":"Schulz, J. B. et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol 5, 222\u2013234, https:\/\/doi.org\/10.1038\/nrneurol.2009.26 (2009).","journal-title":"Nat Rev Neurol"},{"key":"49821_CR75","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nn.3460","volume":"16","author":"MM Dobbin","year":"2013","unstructured":"Dobbin, M. M. et al. SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat Neurosci 16, 1008\u20131015, https:\/\/doi.org\/10.1038\/nn.3460 (2013).","journal-title":"Nat Neurosci"},{"key":"49821_CR76","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1212\/NXG.0000000000000056","volume":"2","author":"L Addis","year":"2016","unstructured":"Addis, L. et al. Analysis of rare copy number variation in absence epilepsies. Neurol Genet 2, e56, https:\/\/doi.org\/10.1212\/NXG.0000000000000056 (2016).","journal-title":"Neurol Genet"},{"key":"49821_CR77","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamaneurol.2017.1775","volume":"74","author":"F Borlot","year":"2017","unstructured":"Borlot, F., Regan, B. M., Bassett, A. S., Stavropoulos, D. J. & Andrade, D. M. Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability. JAMA Neurol 74, 1301\u20131311, https:\/\/doi.org\/10.1001\/jamaneurol.2017.1775 (2017).","journal-title":"JAMA Neurol"},{"key":"49821_CR78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ejhg.2013.93","volume":"22","author":"G McMichael","year":"2014","unstructured":"McMichael, G. et al. Rare copy number variation in cerebral palsy. Eur J Hum Genet 22, 40\u201345, https:\/\/doi.org\/10.1038\/ejhg.2013.93 (2014).","journal-title":"Eur J Hum Genet"},{"key":"49821_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8949","volume":"6","author":"M Oskoui","year":"2015","unstructured":"Oskoui, M. et al. Clinically relevant copy number variations detected in cerebral palsy. Nat Commun 6, 7949, https:\/\/doi.org\/10.1038\/ncomms8949 (2015).","journal-title":"Nat Commun"},{"key":"49821_CR80","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/WNL.0000000000001494","volume":"84","author":"R Segel","year":"2015","unstructured":"Segel, R. et al. Copy number variations in cryptogenic cerebral palsy. Neurology 84, 1660\u20131668, https:\/\/doi.org\/10.1212\/WNL.0000000000001494 (2015).","journal-title":"Neurology"},{"key":"49821_CR81","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res 33, W382\u2013388, https:\/\/doi.org\/10.1093\/nar\/gki387 (2005).","journal-title":"Nucleic Acids Res"},{"key":"49821_CR82","doi-asserted-by":"publisher","first-page":"e23235","DOI":"10.1371\/journal.pone.0023235","volume":"6","author":"M Vazquez-Cedeira","year":"2011","unstructured":"Vazquez-Cedeira, M., Barcia-Sanjurjo, I., Sanz-Garcia, M., Barcia, R. & Lazo, P. A. Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2. PLoS One 6, e23235, https:\/\/doi.org\/10.1371\/journal.pone.0023235 (2011).","journal-title":"PLoS One"},{"key":"49821_CR83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.153.3.613","volume":"153","author":"I Rappold","year":"2001","unstructured":"Rappold, I., Iwabuchi, K., Date, T. & Chen, J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell. Biol. 153, 613\u2013620 (2001).","journal-title":"J. Cell. Biol."},{"key":"49821_CR84","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1016\/S0021-9258(17)37101-6","volume":"269","author":"DM Milne","year":"1994","unstructured":"Milne, D. M., Campbell, D. G., Caudwell, F. B. & Meek, D. W. Phosphorylation of tumor suppressor protein p53 by mitogen-activated protein kinase. J. Biol. Chem. 269, 9253\u20139260 (1994).","journal-title":"J. Biol. Chem."},{"key":"49821_CR85","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.virol.2004.08.013","volume":"328","author":"CR Santos","year":"2004","unstructured":"Santos, C. R., Vega, F. M., Blanco, S., Barcia, R. & Lazo, P. A. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism. Virology 328, 254\u2013265, https:\/\/doi.org\/10.1016\/j.virol.2004.08.013 (2004).","journal-title":"Virology"},{"key":"49821_CR86","first-page":"1361","volume":"7","author":"DM Milne","year":"1992","unstructured":"Milne, D. M., Palmer, R. H., Campbell, D. G. & Meek, D. W. Phosphorylation of the p53 tumour-suppressor protein at the three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene 7, 1361\u20131369 (1992).","journal-title":"Oncogene"},{"key":"49821_CR87","unstructured":"Bremer, M. & Doerge, R. M. Statistics at the bench: a step-by step handbook for biologists. (Cold Spring Harbor Laboratory Press, 2009)."},{"issue":"10","key":"49821_CR88","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41372-018-0199-3","volume":"38","author":"Adi Reches","year":"2018","unstructured":"Reches, A. et al. Whole-exome sequencing in fetuses with central nervous system abnormalities. J Perinatol, https:\/\/doi.org\/10.1038\/s41372-018-0199-3 (2018).","journal-title":"Journal of Perinatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49821-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:39:46Z","timestamp":1671284386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49821-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49821-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13381"}}